Top compounds associated with response to GADL1


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC 0.098 0.001
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA foretinib GDSC1000 pan-cancer AAC 0.1 0.002
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Camptothecin GDSC1000 pan-cancer AAC 0.11 0.002
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC 0.18 0.002
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.099 0.002
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.1 0.002
Download CSV